Floodlight™ MS' mission is to improve the lives of people affected by Multiple Sclerosis. By tracking the patient physical and cognitive status over time, it enables better conversations and care decisions with their healthcare provider.

Overview

Floodlight™ MS is comprised of a patient-facing native app for iOS and Android and a web-based portal used by healthcare practitioners. It is an FDA-approved medical device available only through a doctor's prescription.

I was a design consultant for Floodlight™ MS for a year.

Impact

• Reduced decision-making time from 2 weeks to 1-3 days and enabled longer-term product roadmaps. Read about it here: Improving Floodlight™ MS internal processes

• Delivered strategy and multiple features to improve patient adherence. Read about it here: Improving Floodlight™ MS patient adherence

• Delivered a journal feature to improve data contextualisation. Read about it here: Improving Floodlight™ MS data contextualisation

Learnings

• FDA-approved digital devices face unique challenges. Changes to the device’s intended use (for example, from data visualisation to data interpretation), can trigger re-submission for approval, which is costly and takes a minimum of 90 days.

• Testing with real users is imperative when working with people who have some degree of disability, which in the case of MS can be both physical and cognitive.

• Translations are a huge factor that greatly impacted our workflow: working closely with the localisation team was key to avoiding delays in releases.